Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212327 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ana Maria Castro Ferreira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil. Hauptthemen laut MEDLINE: CTLA-4 Antigen, Melanoma, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Coordination for the Improvement of Higher Education Personnel (CAPES).
Abstract (Originalsprache)
This study aimed to verify whether germline single nucleotide variants (SNV) in CTLA-4 gene, c.-1765C>T, c.-1661A>G, c.-1577G>A, and c.-1478G>A, influence the risk, clinicopathological aspects, and survival of patients with CM, as well as its functional consequences. A total of 432 patients with CM and 504 controls were evaluated. CTLA-4 genotypes were identified by real-time polymerase chain reaction (RT-PCR) and expression of CTLA-4 by quantitative PCR (qPCR) and luciferase assay. Cell cycle, proliferation, apoptosis/necrosis, and migration analyses were performed in SK-MEL-28 and A-375 cell lines modified to present homozygous ancestral or variant genotypes by CRISPR technique. Individuals with the CTLA-4 c.-1577 AA genotype and the combined CTLA-4 c.-1577 and c.-1478 AA + AA genotypes were at 1.60- and 3.12-fold higher risk of developing CM, respectively. The CTLA-4 c.-1577 AA genotype was seen as an independent predictor of worse event-free survival and was also associated with higher gene expression, higher cell proliferation, lower cell apoptosis, and higher cell migration. Our data present, for the first time, evidence that CTLA-4 c.-1577G>A alters the risk and clinical aspects of CM treated with conventional procedures and may be used for selecting individuals for tumor prevention and patients for distinct treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Genetics, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.
- Department of Anesthesiology, Oncology and Radiology, School of Medical Sciences, State University of Campinas, Campinas 13083-970, SP, Brazil.
- Melanoma and Sarcoma Surgery Department, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
- Department of Medical Oncology, Barretos Cancer Hospital, Barretos 14784-400, SP, Brazil.
ORCID-Profile: Juliana Carron, Gabriela Vilas Bôas Gomez, Vinicius de Lima Vazquez, Gustavo Jacob Lourenço, Carmen Silvia Passos Lima
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Coordination for the Improvement of Higher Education Personnel (CAPES)
Zitieren
APA
Ferreira, A. M. C., Carron, J., Gomez, G. V. B., Vazquez, V. L., Serrano, S. V., Lourenço, G. J., & Lima, C. S. P. (2024). Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212327
Vancouver
Ferreira AMC, Carron J, Gomez GVB, Vazquez VL, Serrano SV, Lourenço GJ, et al. Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212327
BibTeX
@article{Ferreira2024,
author = {Ferreira, Ana Maria Castro and Carron, Juliana and Gomez, Gabriela Vilas Bôas and Vazquez, Vinicius de Lima and Serrano, Sergio Vicente and Lourenço, Gustavo Jacob and Lima, Carmen Silvia Passos},
title = {Association of Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) Genetic Variants with Risk and Outcome of Cutaneous Melanoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212327}
}
EUVIMED